Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06526819 · ClinicalTrials.gov registry record · Phase 1

SMP-3124LP in Adults With Advanced Solid Tumors

A Phase 1 study of Solid Tumor, sponsored by Sumitomo Pharma America.

Recruiting
Registry status
Phase 1
Development phase
120
Enrollment target
10
Study locations

NCT06526819 is a Phase 1 study of Solid Tumor that is actively recruiting participants, run by Sumitomo Pharma America. The registered enrollment target is 120 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (46% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06526819, a Phase 1 study of Solid Tumor, is actively recruiting participants, sponsored by Sumitomo Pharma America.

RECRUITING
Registry status
Phase 1
Development phase
120 participants
Enrollment target
10
Study locations

Study Summary

An Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid Tumors

Conditions Studied

Solid Tumor

Interventions

  • DRUG SMP3124LP

Study Locations (10)

Tennessee

  • SCRI Oncology Partners - Nashville
  • Vanderbilt-Ingram Cancer Center - Nashville

Other

  • National Cancer Center Hospital East - Kashiwa-shi
  • Kyoto University Hospital - Kyoto

California

  • Cedars Sinai Medical Center - Los Angeles

Colorado

  • Sarah Cannon Research Institute at HealthOne - Denver

Illinois

  • Northwestern Medicine Cancer Center - Chicago

Ohio

  • Ohio State University - Columbus

Texas

  • MD Anderson Cancer Center - Houston

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-08-14
Est. Completion 2029-05
Phase Phase 1

Sponsor

Sumitomo Pharma America

168 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06526819

The ClinicalTrials.gov registry entry for NCT06526819 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (46% lower). The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which SMP3124LP is the first listed.

NCT06526819 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Tennessee, Other, California.

Frequently Asked Questions

What is clinical trial NCT06526819 about?

NCT06526819 is a clinical study titled "SMP-3124LP in Adults With Advanced Solid Tumors". An Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid Tumors

What is the current status of trial NCT06526819?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2024-08-14. Estimated completion is 2029-05.

What conditions does trial NCT06526819 study?

This clinical trial studies the following conditions: Solid Tumor.

What interventions are being tested in trial NCT06526819?

The interventions under investigation include: SMP3124LP (DRUG).

Who is sponsoring clinical trial NCT06526819?

This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06526819 being conducted?

This trial has 10 study locations across California, Colorado, Illinois, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.